NG

Nitin Gangadhar Rahane

Director Director DIN 03429797
DIN 03429797 First appointment Apr 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Nitin Gangadhar Rahane

Data last updated:

Nitin Gangadhar Rahane was a Director at Citron Life Sciences Private Limited (2013–2019) and Director at Sai Ayur Pharma Private Limited (from 2011). The companies operate in Pharma.

DIN 03429797
Primary Designation Director
Industry Pharma
First Appointment 26 Apr 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Citron Life Sciences Private Limited U24233PN2013PTC146576
Director12 Mar 20132013₹25.5 Lakh (FY 2025)Active
Sai Ayur Pharma Private Limited U74900PN2011PTC139322
Director26 Apr 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sai Ayur Pharma Private Limited
Citron Life Sciences Private Limited
Premium access

Shareholding and investment profile for Nitin Gangadhar Rahane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Gangadhar Rahane

Nitin Gangadhar Rahane was first appointed on 26 Apr 2011 as Director at Sai Ayur Pharma Private Limited. The most recent appointment on record is 12 Mar 2013 at Citron Life Sciences Private Limited.

Nitin Gangadhar Rahane held 2 earlier board appointments: Citron Life Sciences Private Limited (Director, 12 Mar 2013 to 22 Apr 2019); Sai Ayur Pharma Private Limited (Director, from 26 Apr 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available